SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bull_dozer who wrote (39109)3/23/2025 8:56:52 PM
From: Stan  Read Replies (1) of 39305
 
Doctor wants me to take 40 mg Famotidine which is not a PPI but an H2 antagonist (he actually took me off Omeprazole a PPI about 7 years ago over his concerns about its side effects).
It's for a small hiatal hernia and a mild Schatzki ring, but I take them irregularly, only when I am bothered which is thankfully not very often.

I asked Grok anyway about Famotidine in this regard.

Is there a dementia risk with Famotidine, 40 mg tablet once a day?

There is no conclusive evidence directly linking famotidine (a histamine H2-receptor antagonist commonly used to reduce stomach acid) at a dose of 40 mg once daily to an increased risk of dementia.

However, let’s break this down based on available research and considerations:

Famotidine is generally well-tolerated, with common side effects including headache, dizziness, and gastrointestinal issues, but cognitive decline or dementia isn’t a widely recognized side effect.

Concerns about dementia risks have been more prominently associated with other classes of medications, like proton pump inhibitors (PPIs) (e.g., omeprazole) or certain antihistamines
(e.g., first-generation H1 antagonists like diphenhydramine), due to their effects on the brain or
potential to alter nutrient absorption (like vitamin B12, which is linked to cognitive health).

Some studies have explored whether H2 blockers like famotidine could influence cognitive function, particularly in older adults or those with existing risk factors. For instance, research
has suggested a possible association between long-term use of H2 blockers and cognitive impairment, potentially due to their mild anticholinergic effects or changes in brain histamine levels. However, these
findings are not specific to famotidine alone, and the evidence is mixed—correlation doesn’t always mean causation.

A 2016 study in the Journal of the American Geriatrics Society found no significant dementia risk with H2 blockers compared to PPIs, and famotidine is often considered to have a lower anticholinergic burden than other drugs in its class.

At 40 mg once daily, you’re within the typical therapeutic range for conditions like GERD or ulcers (usual doses range from 20-40 mg,

sometimes up to 80 mg daily in divided doses). Short-term or moderate use is unlikely to pose a significant risk based on current data. However, if you’re asking about long-term use (years), age
(especially over 65), or have other dementia risk factors (e.g., family history, cardiovascular issues),
the picture gets murkier—not because of strong evidence against famotidine, but because chronic medication use and aging itself are variables in cognitive health studies.

If this is a personal concern, it’d be worth discussing with a healthcare provider, especially if you’ve noticed cognitive changes or have a specific risk profile. T

hey might weigh alternatives (e.g., lifestyle changes for acid reflux) or monitor you over time.

Want me to dig deeper into any specific studies or X posts on this topic?

Disclaimer: Grok is not a doctor; please consult one. Don't share information that can identify you.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext